Wuhan YZY Biopharma Co Ltd 2024 Sustainability Report
Company: Wuhan YZY Biopharma Co Ltd
Sector: Manufacturing
Country: China
Year: 2024
Type: Sustainability Report
Pages: 30
The report describes YZYBIO's 2024 progress from clinical-stage R&D to Phase III advancement for M701, alongside a RMB 315 million domestic-rights transaction. It reports 542.62 Tonnes of CO 2 equivalent in total greenhouse gas emissions, including 4.78 Tonnes of CO 2 equivalent from Scope 1 and 537.85 Tonnes of CO 2 equivalent from Scope 2. The workforce totaled 122 Persons, and the company reported zero work-related fatalities over the past three years while organizing 91 training sessions.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.